Pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and delay clinical worsening, in adults who are temporarily unable to take oral Revatio. Give by IV bolus injection.

Revatio is Food and Drug Administration (FDA)–approved to treat pulmonary arterial hypertension (PAH). PAH is a condition ...

Sildenafil is the generic equivalent of Pfizer’s Revatio, which is indicated for the treatment of pulmonary arterial hypertension in adults, to improve exercise ability and delay clinical worsening.